Allan Tasman, M.D. is Emeritus Professor and Chair of the Department of Psychiatry and Emeritus Schwab Endowed Chair in Social and Community Psychiatry at the University of Louisville. He completed residency at the University of Cincinnati and psychoanalytic training at the Western New England Institute for Psychoanalysis. He became known nationally and internationally while a faculty member at the University of Connecticut (1976-1991) for his expertise in teaching, mentorship, and educational program development. Through his subsequent national and international work, he has been involved in a broad range of educational, clinical, strategic planning, and mental health policy issues, particularly addressing disparities in health and mental health. His commitment to serving the disadvantaged started in medical school where he founded and was CEO of the Lexington Free Clinic. While psychiatry chair in Louisville, to address health and mental health disparities in the low-income Medicaid population, he conceptualized and spearheaded implementation of Passport Health Plan in the early 1990s.
This innovative non-profit managed care organization, which prioritized the quality of health outcomes and attention to health inequities, was consistently ranked nationally in the highest levels. Passport became the second largest Medicaid system in Kentucky, with a two billion dollar annual budget. He later was a 2018-2023 appointee to the National Advisory Council of the US Substance Abuse and Mental Health Services Administration (SAMHSA). His funded research over four decades has focused on the neurophysiology of cognitive processes. His laboratory at the University of Connecticut was one of the first to describe functional neural abnormalities in offspring of alcohol addict fathers. More recent research in Louisville focused on investigation of innovative neuromodulation treatments for autism and substance abuse. He has authored or edited 38 books, over 260 peer reviewed articles, chapters, and abstracts, nearly 80 editorials in psychiatric publications, and over 400 national and international presentations. He is founding Editor in Chief of all editions of this textbook, now named Tasman''s Psychiatry, with earlier editions called "the best current textbook of psychiatry" by the New England Journal of Medicine and the "gold standard" by the American Journal of Psychiatry.
He also was Editor in Chief from 2014 to 2019 of Psychiatric Times, the psychiatric publication most widely read by psychiatrists in the United States. He was president of the American Association of Directors of Psychiatric Residency Training, the Association for Academic Psychiatry, and two terms for the American Association of Chairs of Departments of Psychiatry. As American Psychiatric Association (APA) president elect and president, he conceptualized and established the American Psychiatric Institute for Research and Education, implemented the initial planning process for DSM 5, and initiated and oversaw a complete corporate reorganization. In 1991, he founded and was Deputy Editor of the American Psychiatric Press Journal of Psychotherapy Practice and Research. In 2005, he was elected to a 6-year term as Secretary for Education of the World Psychiatric Association, where he produced WPA global guidelines for medical student and resident psychiatric education, with special attention to programs in resource poor countries. As President of the Pacific Rim College of Psychiatrists (2006-2008), he conceptualized and established the journal Asia Pacific Psychiatry (Editor in Chief 2014-2023), which is now also the official journal of the Asian Federation of Psychiatric Associations. It is the first transnational English language psychiatric journal focused on the entire Pacific Rim region. He currently serves as Treasurer and Vice President for North America and the Caribbean of the World Federation for Mental Health, collaborating with the WHO and UN.
He has received multiple national and international awards for leadership, educational excellence, and distinguished professional service, including an APA special presidential commendation for career leadership and service. He received distinguished alumnus awards from the University of Kentucky Medical School and Franklin and Marshall College. He is a Fellow of the Royal College of Psychiatrists of the United Kingdom and a number of other organizations including Distinguished Life Fellow of the APA, and an Honorary Fellow of the World Psychiatric Association. He received the American College of Psychiatrists Distinguished Service to Psychiatry Award, their highest honor. He is the 2024 recipient of the prestigious C. Charles Burlingame Award for excellence in administration, research, and education. Michelle B.Riba,M.
D., M.S.,DFAPA, FAPM is Professor of Psychiatry, University of Michigan Medical School; Director of the PsychOncology Program at the University of Michigan Rogel Cancer Center; and Co-director of the Workplace Mental Health Program at the University of Michigan Eisenberg Family Depression Center. Dr. Riba is a board-certified consultation-liaison psychiatrist. She formerly served as Associate Chair for Education and Academic Affairs, Associate Chair for Integrated Medical and Psychiatric Services, Director of Residency Training and Director of the Consultation Liaison Fellowship in the University of Michigan Department of Psychiatry, and Associate Chair in the University of Michigan Comprehensive Depression Center. She has served as President of the American Psychiatric Association, Association for Academic Psychiatry, and American Association of Directors of Psychiatric Residency Training, as well as Secretary for Scientific Publication of the World Psychiatric Association and on the Board of the Directors of the Pacific Rim College of Psychiatrists.
Dr. Riba is Chair of the National Comprehensive Cancer Network (NCCN) Distress Guidelines, as well as a member of the NCCN Fatigue Guidelines. She has served as the American Medical Association''s representative to the American College of Surgeons Commission on Cancer, the AAMC Council of Academic Societies-Leadership Development Committee, the World Federation for Mental Health Scientific Committee and Program Chair, and the Association of Women Psychiatrists Executive Council; Trustee of the American Association for Emergency Psychiatry, the Society for Clinical and Translation Science, American College of Psychiatrists PRITE Commission, and Institute of Medicine Committee on Incorporating Research into Psychiatry Residency Training. Dr. Riba received the Nancy C.A. Roeske, MD APA Award for Excellence in Medical Student Teaching from the University of Connecticut and the University of Michigan; the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women; the APA Irma Bland Award for Excellence in Teaching Residents; the Outstanding Clinician Award from the University of Michigan; the University of Michigan Making a Difference Award; Special Recognition Award from the Academy of Psychosomatic Medicine; Inaugural member, Distinguished Life Fellows, Association for Academic Psychiatry; American College of Psychiatrists Distinguished Service Award; American Psychiatric Association Distinguished Service Award; Association of Women Psychiatrists/APA Alexandra Symonds Award; and Special Recognition Award, Indo-American Psychiatric Association for Leadership Exceptional Achievements and Dedication to Minority Psychiatrists. She is the 2024 recipient of the Academy of Consultation-Liaison Psychiatry Distinguished Service Award.
Dr. Riba is the author or editor of over 300 scientific articles, books, chapters, and scientific abstracts. She is Editor-in-Chief, Current Psychiatry Reports, Springer. Dr. Riba has served on the editorial board of Psychiatric Services and Cancer News on the Net, Current Psychiatry, Academic Psychiatry, and Hospital and Community Psychiatry, and has served on the editorial advisory board of the American Psychiatric Press, Inc. She is a reviewer for many international journals, including Psycho-Oncology, Academic Psychiatry, Psychiatric Services, Journal of Psychiatric Practice, Psychosomatic Medicine, and Breast Cancer Research and Treatment. She has co-edited fifteen editions of the American Psychiatric Press Review of Psychiatry series. She has co-edited Psychopharmacology and Psychotherapy: A Collaborative Approach, APPI, Inc.
; Primary Care Psychiatry, Saunders; The Doctor-Patient Relationship in Pharmacotherapy: Improving Treatment Effectiveness, Guilford; and Psychopharmacology in Oncology and Palliative Care: A Practice Manual, Springer. Dr. Riba has edited or co-written over 40 books. She is the senior author of Competency in Combining Pharmacotherapy and Psychotherapy, APPI, Inc.; Clinical Manual of Emergency Psychiatry, APPI, Inc. (First and Second Edition); Psychiatry and Heart Disease, John Wiley and Sons, Inc.; Physician Mental.